Weight Bearing Status Post-hip Arthroscopy
Launched by UNIVERSITY OF PITTSBURGH · Feb 7, 2023
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study will be conducted at UPMC St. Margaret's Hip Preservation Program. Consented patients who undergo acetabular labral repair and femoroplasty will be included in randomization of weight-bearing status. Two separate protocols will be created to indicate weight bearing status, either WBAT immediately post-op or FFWB immediately post-op, to distribute to rehabilitation staff to ensure compliance. Immediately after the surgical procedure, the surgeon will be blinded and a randomized pamphlet with post-operative instructions with weight bearing education will be given to PACU nursing sta...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age\>= 12 years
- • Diagnoses: femoroacetabular impingement and hip labral tears.
- • Surgical procedures performed: Hip arthroscopy with femoroplasty and labral repair.
- • Surgery completed at UPMC Children's or UPMC St. Margaret's Hospital
- • unilateral and bilateral hip patients
- Exclusion Criteria:
- • MSK tumor-related FAI or dysplasia
- • generalized hypermobility
- • revision surgeries
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials